These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 31067124)

  • 1. The Pharmacist's Expanding Role in HIV Pre-Exposure Prophylaxis.
    Farmer EK; Koren DE; Cha A; Grossman K; Cates DW
    AIDS Patient Care STDS; 2019 May; 33(5):207-213. PubMed ID: 31067124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploratory survey of Florida pharmacists' experience, knowledge, and perception of HIV pre-exposure prophylaxis.
    Shaeer KM; Sherman EM; Shafiq S; Hardigan P
    J Am Pharm Assoc (2003); 2014; 54(6):610-7. PubMed ID: 25343624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding community pharmacist perceptions and knowledge about HIV preexposure prophylaxis (PrEP) therapy in a Mountain West state.
    Unni EJ; Lian N; Kuykendall W
    J Am Pharm Assoc (2003); 2016; 56(5):527-532.e1. PubMed ID: 27594106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV pre-exposure prophylaxis: Exploring the potential for expanding the role of pharmacists in public health.
    Okoro O; Hillman L
    J Am Pharm Assoc (2003); 2018; 58(4):412-420.e3. PubMed ID: 29789257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attitudes about community pharmacy access to HIV prevention medications in California.
    Koester KA; Saberi P; Fuller SM; Arnold EA; Steward WT
    J Am Pharm Assoc (2003); 2020; 60(6):e179-e183. PubMed ID: 32665097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacists as providers of HIV pre-exposure prophylaxis.
    Bruno C; Saberi P
    Int J Clin Pharm; 2012 Dec; 34(6):803-6. PubMed ID: 23073703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparing for pre-exposure prophylaxis: perceptions and readiness of Canadian pharmacists for the implementation of HIV pre-exposure prophylaxis.
    Yoong D; Naccarato M; Sharma M; Wilton J; Senn H; Tan DH
    Int J STD AIDS; 2016 Jul; 27(8):608-16. PubMed ID: 26025254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting Pharmacist Dispensing Practices and Comfort Related to Pre-exposure Prophylaxis for HIV Prevention (PrEP).
    Meyerson BE; Dinh PC; Agley JD; Hill BJ; Motley DN; Carter GA; Jayawardene W; Ryder PT
    AIDS Behav; 2019 Jul; 23(7):1925-1938. PubMed ID: 30607758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Pharmacist-Led, Same-Day, HIV Pre-Exposure Prophylaxis Initiation Program to Increase PrEP Uptake and Decrease Time to PrEP Initiation.
    Khosropour CM; Backus KV; Means AR; Beauchamps L; Johnson K; Golden MR; Mena L
    AIDS Patient Care STDS; 2020 Jan; 34(1):1-6. PubMed ID: 31944854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of a community pharmacy-based pre-exposure prophylaxis service: a novel model for pre-exposure prophylaxis care.
    Tung EL; Thomas A; Eichner A; Shalit P
    Sex Health; 2018 Nov; 15(6):556-561. PubMed ID: 30401342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Considering Stigma in the Provision of HIV Pre-Exposure Prophylaxis: Reflections from Current Prescribers.
    Calabrese SK; Tekeste M; Mayer KH; Magnus M; Krakower DS; Kershaw TS; Eldahan AI; Gaston Hawkins LA; Underhill K; Hansen NB; Betancourt JR; Dovidio JF
    AIDS Patient Care STDS; 2019 Feb; 33(2):79-88. PubMed ID: 30715918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient perspectives of pharmacists prescribing HIV pre-exposure prophylaxis: A survey of patients receiving antiretroviral therapy.
    Lutz S; Heberling M; Goodlet KJ
    J Am Pharm Assoc (2003); 2021; 61(2):e75-e79. PubMed ID: 33069595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-Exposure Prophylaxis: A Narrative Review of Provider Behavior and Interventions to Increase PrEP Implementation in Primary Care.
    Silapaswan A; Krakower D; Mayer KH
    J Gen Intern Med; 2017 Feb; 32(2):192-198. PubMed ID: 27761767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midwest pharmacists' familiarity, experience, and willingness to provide pre-exposure prophylaxis (PrEP) for HIV.
    Broekhuis JM; Scarsi KK; Sayles HR; Klepser DG; Havens JP; Swindells S; Bares SH
    PLoS One; 2018; 13(11):e0207372. PubMed ID: 30427912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation.
    Liu AY; Hessol NA; Vittinghoff E; Amico KR; Kroboth E; Fuchs J; Irvin R; Sineath RC; Sanchez T; Sullivan PS; Buchbinder SP
    AIDS Patient Care STDS; 2014 Dec; 28(12):622-7. PubMed ID: 25396706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the use of an infographic on pre-exposure prophylaxis for Wisconsin community pharmacists.
    Tidd M; Shiyanbola O; Ford JH; Richert L
    J Am Pharm Assoc (2003); 2022; 62(6):1897-1903.e4. PubMed ID: 35989150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV.
    Auerbach JD; Kinsky S; Brown G; Charles V
    AIDS Patient Care STDS; 2015 Feb; 29(2):102-10. PubMed ID: 25513954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review.
    Pleuhs B; Quinn KG; Walsh JL; Petroll AE; John SA
    AIDS Patient Care STDS; 2020 Mar; 34(3):111-123. PubMed ID: 32109141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation Science of Integrating Pre-Exposure Prophylaxis in Pharmacist-Led Services in the United States.
    Chandra C; Hudson AF; Alohan DI; Young HN; Crawford ND
    Curr HIV/AIDS Rep; 2024 Aug; 21(4):197-207. PubMed ID: 38775937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementing a collaborative practice agreement for HIV pre-exposure prophylaxis in the primary care setting.
    Lee LC; Pollak BA; Coffey CP
    J Am Pharm Assoc (2003); 2023; 63(1):383-388. PubMed ID: 36244883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.